Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by forhandlaren


V.SBM

RE:Back to zero volume

I encourage everyone that is not satisfied with the volume to buy some shares...

February 11, 2022

V.SBM

RE:RE:RE:RE:RE:RE:0.27

The top-10 partner funded the clinical trial so it makes sense that this...

February 10, 2022

V.SBM

RE:25.8 cents Germany

Well, it's about time for the share price to bounce back. I'd say...

February 8, 2022

V.SBM

RE:Can someone run some npvs?

Using the suggested numbers by PRC of 8 billion USD market value, 5 percent...

February 8, 2022

V.SBM

RE:Antiviral compounds

In the quartely update the company states: "We are excited to report...

February 1, 2022

V.SBM

RE:RE:RE:RE:RE:RE:CFO just exercised

The exercise of warrants in January by management represent about three...

January 28, 2022

V.SBM

RE:RE:Skin Whitening Article on CNN News online tonight

navajojoe - with the high number of likes I'm sure you're a skilled...

January 26, 2022

V.SBM

RE:RE:We are in the negotiation phase with a global top 10 pharma

I choose to put my trust to Linda Pullan. She wouldn't bother to sign up...

January 21, 2022

V.SBM

On the bright side

A lot of things can be improved with the company, but let's focus on the...

January 10, 2022

V.SBM

RE:RE:Open Letter to Management

Theory put into practise. The next announcement regarding a TFC-1067 deal...

January 3, 2022

V.SBM

RE:Open Letter to Management

To be clear. There is an imminent need to build trust on which expectations...

January 3, 2022

V.SBM

Open Letter to Management

Dear Management, The closing price for 2021 was 0.175 compared to 0.325 in...

January 1, 2022

V.SBM

RE:Simplified antiviral NVP

I have adjusted the model in two ways. CAGR of 28 percent for 15 years is...

December 21, 2021

V.SBM

RE:RE:Simplified antiviral NVP

The minimum share price at launch on NASDAQ must be above USD 5.00 equivalent...

December 20, 2021

V.SBM

RE:RE:RE:RE:RE:I hate to say it..

I don't mind different views, but you're just childish. What a waste...

December 20, 2021

V.SBM

RE:RE:RE:I hate to say it..

The current valuation reflects that Howard is out of carrots that would feed...

December 20, 2021

V.SBM

RE:I hate to say it..

You need to learn to distinguish between business and science. So far the...

December 20, 2021

V.SBM

Simplified antiviral NVP

The antiviral Remdesivir is used for SARS-CoV-2-virus treatment. The market...

December 20, 2021

V.SBM

Dyschromia market size?

I havn't found any estimation of Dyschromia market size. Does anyone know...

December 20, 2021

V.SBM

RE:This could be huge

Seems like the company finally will break-through in 2022.

December 20, 2021